Pathobiology and prognosis of chromophobe renal cell carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 26, Issue 6, 2008, Pages 604-609

  Klatte, Tobias ^a   Han, Ken ryu ^a   Said, Jonathan W ^a   Böhm, Malte ^b   Allhoff, Ernst Peter ^b   Kabbinavar, Fairooz F ^a   Belldegrun, Arie S ^a   Pantuck, Allan J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Chromophobe; Immunotherapy; Sarcomatoid; Survival

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 2;

ADULT; ARTICLE; CANCER GRADING; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; FEMALE; HUMAN; KIDNEY CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHRECTOMY; PATHOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SIROLIMUS; SURVIVAL RATE;

EID: 55249116587     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.07.015     Document Type: Article

References (29)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Thoenes W., Störkel S., Rumpelt H.J., et al. Chromophobe cell renal carcinoma and its variants-a report on 32 cases. J Pathol 155 (1988) 277-287
3. Cindolo L., De la Taille A., Schips L., et al. Chromophobe renal cell carcinoma: Comprehensive analysis of 104 cases from multicenter European database. Urology 65 (2005) 681-686
4. Novick A.C. Kidney cancer: Past, present, and future. Urol Oncol 25 (2007) 188-195
5. Verhoest G., Veillard D., Guillé F., et al. Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma. Eur Urol 51 (2007) 1298-1304
6. Polascik T.J., Bostwick D.G., and Cairns P. Molecular genetics and histopathologic features of adult distal nephron tumors. Urology 60 (2002) 941-946
7. Thoenes W., Störkel S., and Rumpelt H.J. Histopathology and classification of renal cell tumors (adenomas, oncocytomas, and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181 (1986) 125-143
8. Tickoo S.K., Amin M.B., and Zarbo R.J. Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: Emphasis on technique and patterns of staining. Am J Surg Pathol 22 (1998) 419-424
9. Huo L., Sugimura J., Tretiakova M.S., et al. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Hum Pathol 36 (2005) 262-268
10. Leroy X., Moukassa D., Copin M.C., et al. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma. Eur Urol 37 (2000) 484-487
11. Beck S.D., Patel M.I., Snyder M.E., et al. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol 11 (2004) 71-77
12. Cangiano T., Liao J., Naitoh J., et al. Sarcomatoid renal cell carcinoma: Biologic behavior, prognosis, and response to combined surgical resection and immunotherapy. J Clin Oncol 17 (1999) 523-528
13. Cheville J.C., Lohse C.M., Zincke H., et al. Sarcomatoid renal cell carcinoma: An examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 28 (2004) 435-441
14. Akhtar M., Tulbah A., Kardar A.H., et al. Sarcomatoid renal cell carcinoma: The chromophobe connection. Am J Surg Pathol 21 (1997) 1188-1195
15. Renshaw A.A., Henske E.P., Loughlin K.R., et al. Aggressive variants of chromophobe renal cell carcinoma. Cancer 78 (1996) 1756-1761
16. Thoenes W., Störkel S., and Rumpelt H.J. Human chromophobe cell renal carcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol 48 (1985) 207-217
17. Kovacs G., Akhtar M., Beckwith B.J., et al. The Heidelberg classification of renal cell tumors. J Pathol 183 (1997) 131-133
18. Sakai Y., Watanabe S., and Matsukuma S. Chromophobe renal cell carcinoma showing oncocytoma-like hyalinized and edematous stroma: A case report and review of the literature. Urol Oncol 22 (2004) 461-464
19. Cochand-Priollet B., Molinié V., Bougaran J., et al. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases. Arch Pathol Lab Med 121 (1997) 1081-1086
20. Brunelli M., Eble J.N., Zhang S., et al. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod Pathol 18 (2005) 161-169
21. Kattan M.W., Reuter V., Motzer R.J., et al. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166 (2001) 63-67
22. Cheville J.C., Lohse C.M., Zincke H., et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27 (2003) 612-624
23. Patard J.J., Leray E., Rioux-Leclercq N., et al. Prognostic value of histologic subtypes in renal cell carcinoma: A multicenter experience. J Clin Oncol 23 (2005) 2763-2771
24. Karakiewicz P.I., Briganti A., Chun F.K., et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol 25 (2007) 1316-1322
25. Motzer R.J., Bacik J., Mariani T., et al. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol 20 (2002) 2376-2381
26. Renshaw A.A., and Richie J.P. Subtypes of renal cell carcinoma. Different onset and sites of metastatic disease. Am J Clin Pathol 111 (1999) 539-543
27. Stadler W.M., Figlin R.A., Ernstoff M.S., et al. The Advanced Renal Cell Carcinoma Sorafenib (ARCCS) expanded access trial: Safety and efficacy in patients with non-clear cell (NCC) renal cell carcinoma (RCC). J Clin Oncol 25 (2007) 5036 (Annual Meeting Proceedings Part I)
28. Hudes G., Carducci M., Tomczak P., et al. Temsirolimus, interferon α, or both for advanced renal-cell carcinoma. N Engl J Med 356 (2007) 2271-2281
29. Dutcher J.P., Szczylik C., Tannir N., et al. Correlation of survival with tumor histology, age, and prognostic risk group for previously untreated patients with advanced renal cell carcinoma (adv RCC) receiving temsirolimus (TEMSR) or interferon-α (IFN). J Clin Oncol 25 (2007) 5033 (Annual Meeting Proceedings Part I)